サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1757979

糖尿病管理における人工知能（AI）の世界市場

Artificial Intelligence (AI) in Diabetes Management

出版日
ページ情報
英文 281 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=145.63円
糖尿病管理における人工知能（AI）の世界市場
出版日: 2025年06月27日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 281 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

糖尿病管理における人工知能（AI）の世界市場は2030年までに214億米ドルに到達

2024年に132億米ドルと推定される糖尿病管理における人工知能（AI）の世界市場は、2024年から2030年にかけてCAGR 8.3％で成長し、2030年には214億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである診断機器は、CAGR 9.3%を記録し、分析期間終了時には140億米ドルに達すると予測されます。グルコースモニタリングデバイスセグメントの成長率は、分析期間中CAGR 7.0％と推定されます。

米国市場は36億米ドル、中国はCAGR13.1％で成長予測

米国の糖尿病管理における人工知能（AI）市場は2024年に36億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに47億米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは13.1%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ4.2%と8.0%と予測されています。欧州では、ドイツがCAGR 5.6%で成長すると予測されています。

世界の糖尿病管理における人工知能（AI）市場- 主要動向と促進要因まとめ

AIは糖尿病管理における個別化ケアに革命をもたらすか？

人工知能（AI）は、これまでにないレベルの個別化、精密化、プロアクティブケアを可能にすることで、糖尿病管理の状況を再定義しつつあります。従来、糖尿病治療は、定期的なグルコース測定、標準的な投薬スケジュール、患者のセルフモニタリングに大きく依存した、反応的で一般化されたアプローチを特徴としてきました。しかし、AIを搭載したシステムの登場により、糖尿病治療はダイナミックでリアルタイムな個別化モデルへと移行しつつあります。機械学習アルゴリズムは現在、持続グルコースモニター（CGM）、インスリンポンプ、フィットネストラッカー、電子カルテからの膨大なデータストリームを分析し、パターンを特定し、血糖値の変動を事前に予測することができます。このような洞察により、患者は症状が出る前であっても、食事や活動レベルの調整などの予防的行動をとることができるようになります。AI対応プラットフォームは、リアルタイムのインスリン投与推奨や、しばしば「人工膵臓」技術と呼ばれる、予測分析に基づいてインスリンを自動投与するクローズドループ・システムもサポートします。さらに、これらのシステムは、モバイルアプリを通じてオーダーメイドのコーチングやライフスタイルガイダンスを提供し、アドヒアランスと長期予後を向上させる。さらに、非構造化臨床記録から洞察を引き出すために自然言語処理が利用され、AIチャットボットは24時間365日のサポートとリマインダーを提供しています。これらの技術革新の総体として、患者の認知的負担を軽減し、合併症を最小限に抑え、糖尿病管理をより迅速かつ持続可能なものにしています。AIが多様な患者集団と進化する医療データから学び続けることで、インテリジェントで患者中心の糖尿病ケアの新たなスタンダードが確立されつつあります。

デジタルヘルスエコシステムと遠隔モニタリングは、どのようにAIの役割を拡大しているのか？

拡大するデジタルヘルスエコシステムは、特に遠隔モニタリングと遠隔医療ソリューションを通じて、AIが包括的な糖尿病管理において中心的な役割を果たすための肥沃な土壌を提供しています。COVID-19の大流行はデジタルヘルスツールの採用を加速させ、糖尿病ケアは最も大きな変革を経験した分野のひとつです。バーチャル診察への依存度が高まる中、AI対応プラットフォームは、臨床環境外で患者の状態をモニタリングするために不可欠となりました。高血糖や低血糖などの危険な動向をリアルタイムでヘルスケアプロバイダーや患者に警告するために、AIアルゴリズムと組み合わせた遠隔グルコースモニタリングデバイスが使用されるようになりました。これらのシステムは、臨床医が介入に優先順位をつけ、緊急の病院受診を減らすのに役立っています。AIはまた、動的なリスク層別化をサポートし、医師が個々のリスクプロファイルに基づいてリソースを配分し、ケアプランをカスタマイズすることを可能にします。ウェアラブルデバイスやスマートフォンとの統合により、身体活動、睡眠、食事摂取量などのコンテキストデータの収集が可能になります。このような包括的な追跡は、1型糖尿病と2型糖尿病を併発する患者の管理に特に有益です。さらにAIは、匿名化されたデータを集約して地域動向、投薬効果、ケア提供におけるギャップを特定することで、大規模な集団健康管理を可能にしています。内分泌専門医へのアクセスが制限されている農村部や十分なサービスを受けていない地域では、AI主導のバーチャル・ケア・プラットフォームがギャップを埋め、タイムリーで一貫性のあるケアを提供しています。デジタル・ヘルス・エコシステムがより洗練されるにつれて、AIは、統合されたケアの連続体において、機器、医療提供者、患者をつなぐ中心的なインテリジェンス層になる準備が整っています。

AIは早期発見と予測的介入のパラダイムを変えるか？

AIは、糖尿病に関連する合併症の早期発見と予測において、治療の焦点を治療から予防へと根本的にシフトさせる、画期的な存在であることが証明されつつあります。糖尿病管理におけるAIの最も強力な応用のひとつは、その予測能力にあります。電子カルテ、遺伝子プロファイル、画像診断結果、生体測定データなどの膨大なデータセットを利用することで、機械学習モデルは、症状が顕在化するずっと前に、糖尿病発症の早期警告サインを特定することができます。2型糖尿病を発症するリスクのある患者に対しては、AIツールがリスクスコアを作成し、的を絞った生活習慣の改善を推奨することで、病気の進行を防ぐことができます。診断された患者では、人間の目には見えない微妙なパターンを検出することで、糖尿病網膜症、腎症、神経障害、心血管疾患などの合併症を予測するためにAIが使用されています。例えば、AIを活用した網膜画像システムは、専門医の介入を必要とせずに糖尿病性眼疾患をスクリーニングするために、プライマリケアクリニックに導入されています。同様に、AIモデルは臨床医が入院やインスリン抵抗性の可能性を判断するのに役立ち、タイムリーな介入を可能にしています。AIはまた、適切な患者コホートを特定し、治療アドヒアランスを予測し、より高い精度で転帰をモニタリングすることで、臨床試験デザインに革命をもたらしています。その結果、製薬会社やヘルスケアシステムは、研究の強化、コスト削減、ケア経路のパーソナライズを目的としたAIツールへの投資を増やしています。このプロアクティブなアプローチは、臨床転帰を改善するだけでなく、長期的なヘルスケア支出を削減します。要するに、AIは糖尿病管理を上流に押し上げ、より早期の特定、予測的対応、そして最終的には疾病予防へと導いているのです。

糖尿病管理におけるAIの世界の急速な普及の原動力は？

糖尿病管理における人工知能（AI）市場の成長は、テクノロジーの進歩、ヘルスケアの変革、患者の期待の進化に根ざしたいくつかの要因によって牽引されています。5億人以上が罹患していると推定される糖尿病の世界の有病率の増加により、従来の臨床モデルを超えるスケーラブルで費用対効果の高いソリューションが急務となっています。リアルタイムのデータ駆動型意思決定支援を大規模に提供できるAIの能力は、この課題への対応に理想的です。センサー、ウェアラブル、モバイル・プラットフォームの技術的進歩により、相互に接続されたエコシステムが構築され、データが継続的かつ目立たずに収集され、AI分析の原材料となります。消費者側では、パーソナライズされた洞察を提供し、セルフケアの負担を軽減し、生活の質を向上させるデジタルヘルスツールに対する需要が高まっています。医療提供者の立場では、AIソリューションは、ルーチン・タスクの自動化、実用的なアラートの生成、診断精度の向上により、臨床医の燃え尽きを軽減するのに役立ちます。クラウドプラットフォーム、電子カルテ、遠隔医療システムへのAIの統合は、相互運用性と拡張性をさらにサポートします。規制機関や支払者は、慢性疾患管理におけるAIの価値を認識し始めており、保険償還の適用範囲拡大や政策支援につながっています。さらに、医療技術企業、製薬企業、AI新興企業間の戦略的投資と提携が、製品開発と市場開拓を加速させています。新興国においては、モバイルファーストのAIアプリケーションが遠隔地の人々へのケア拡大を支援し、質の高い糖尿病ケアへのアクセスを民主化しています。これらの要因が相まって、AIが糖尿病管理のための新しいインテリジェントなパラダイムの中心に立つ、強固で急成長する世界市場が形成されつつあります。

セグメント

デバイス（診断デバイス、グルコースモニタリングデバイス、インスリンデリバリーデバイス）、テクニック（ケースベース推論テクニック、インテリジェントデータ分析テクニック）

調査対象企業の例（全47件）

  • Abbott Laboratories
  • Apple Inc.
  • Beta Bionics
  • Bigfoot Biomedical, Inc.
  • Dexcom, Inc.
  • Diabeloop SA
  • DreaMed Diabetes Ltd.
  • Eyenuk, Inc.
  • Glooko Inc.
  • Google Inc.
  • IBM Corporation
  • Insulet Corporation
  • Medtronic PLC
  • Nemaura Medical Inc.
  • Novo Nordisk A/S
  • Roche Holding AG
  • Sanofi SA
  • Tandem Diabetes Care, Inc.
  • Virta Health Corp.
  • Wellthy Therapeutics Pvt. Ltd.

AI統合

私たちは、有効な専門家コンテンツとAIツールによって、市場情報と競合情報を変革しています。

Global Industry Analystsは、LLMや業界固有のSLMを照会する一般的な規範に従う代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP36203

Global Artificial Intelligence (AI) in Diabetes Management Market to Reach US$21.4 Billion by 2030

The global market for Artificial Intelligence (AI) in Diabetes Management estimated at US$13.2 Billion in the year 2024, is expected to reach US$21.4 Billion by 2030, growing at a CAGR of 8.3% over the analysis period 2024-2030. Diagnostic Devices, one of the segments analyzed in the report, is expected to record a 9.3% CAGR and reach US$14.0 Billion by the end of the analysis period. Growth in the Glucose Monitoring Devices segment is estimated at 7.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$3.6 Billion While China is Forecast to Grow at 13.1% CAGR

The Artificial Intelligence (AI) in Diabetes Management market in the U.S. is estimated at US$3.6 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$4.7 Billion by the year 2030 trailing a CAGR of 13.1% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.2% and 8.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.6% CAGR.

Global Artificial Intelligence (AI) in Diabetes Management Market - Key Trends & Drivers Summarized

Is AI Revolutionizing Personalized Care in Diabetes Management?

Artificial Intelligence (AI) is redefining the landscape of diabetes management by enabling unprecedented levels of personalization, precision, and proactive care. Traditionally, diabetes treatment has been characterized by reactive and generalized approaches, relying heavily on periodic glucose measurements, standard medication schedules, and patient self-monitoring. However, with the advent of AI-powered systems, diabetes care is transitioning into a dynamic, real-time, and individualized model. Machine learning algorithms can now analyze massive streams of data from continuous glucose monitors (CGMs), insulin pumps, fitness trackers, and electronic health records to identify patterns and predict fluctuations in blood glucose levels before they happen. These insights empower patients to take preventive actions, such as adjusting their diet or activity level, even before symptoms arise. AI-enabled platforms also support real-time insulin dosing recommendations and closed-loop systems, often referred to as “artificial pancreas” technologies, which automatically administer insulin based on predictive analytics. Moreover, these systems provide tailored coaching and lifestyle guidance through mobile apps, enhancing adherence and long-term outcomes. Natural language processing is further being used to extract insights from unstructured clinical notes, while AI chatbots offer 24/7 support and reminders. Collectively, these innovations are reducing the cognitive burden on patients, minimizing complications, and making diabetes management more responsive and sustainable. As AI continues to learn from diverse patient populations and evolving medical data, it is setting a new standard for intelligent, patient-centric diabetes care.

How Are Digital Health Ecosystems and Remote Monitoring Expanding AI’s Role?

The expanding digital health ecosystem is providing fertile ground for AI to play a central role in comprehensive diabetes management, especially through remote monitoring and telemedicine solutions. The COVID-19 pandemic accelerated the adoption of digital health tools, and diabetes care was among the areas that experienced the most significant transformation. With increased reliance on virtual consultations, AI-enabled platforms became critical for monitoring patient conditions outside of clinical settings. Remote glucose monitoring devices paired with AI algorithms are now used to alert healthcare providers and patients to dangerous trends, such as hyperglycemia or hypoglycemia, in real time. These systems help clinicians prioritize interventions and reduce emergency hospital visits. AI also supports dynamic risk stratification, enabling physicians to allocate resources and customize care plans based on individual risk profiles. Integration with wearable devices and smartphones allows for the collection of contextual data-like physical activity, sleep, and food intake-which AI models analyze to give holistic insights into patient health. Such comprehensive tracking is particularly beneficial in managing Type 1 and Type 2 diabetes in patients with coexisting conditions. Moreover, AI is enabling large-scale population health management by aggregating anonymized data to identify regional trends, medication effectiveness, and gaps in care delivery. In rural or underserved areas, where access to endocrinologists may be limited, AI-driven virtual care platforms are bridging the gap, providing timely and consistent care. As digital health ecosystems become more sophisticated, AI is poised to become the central intelligence layer connecting devices, providers, and patients in an integrated care continuum.

Is AI Changing the Paradigm of Early Detection and Predictive Intervention?

AI is proving to be a game-changer in the early detection and prediction of diabetes-related complications, fundamentally shifting the focus of care from treatment to prevention. One of the most powerful applications of AI in diabetes management lies in its predictive capabilities. Using vast datasets from electronic health records, genetic profiles, imaging results, and biometric data, machine learning models can identify early warning signs of diabetes onset, long before symptoms become apparent. For individuals at risk of developing Type 2 diabetes, AI tools can generate risk scores and recommend targeted lifestyle changes, thus preventing disease progression. In diagnosed patients, AI is being used to anticipate complications such as diabetic retinopathy, nephropathy, neuropathy, and cardiovascular disease by detecting subtle patterns that are invisible to the human eye. AI-enhanced retinal imaging systems, for example, are being deployed in primary care clinics to screen for diabetic eye disease without the need for specialist intervention. Similarly, AI models are helping clinicians determine the likelihood of hospitalization or insulin resistance, enabling timely intervention. AI is also revolutionizing clinical trial design by identifying suitable patient cohorts, predicting treatment adherence, and monitoring outcomes with greater precision. As a result, pharmaceutical companies and healthcare systems are increasingly investing in AI tools to enhance research, reduce costs, and personalize care pathways. This proactive approach not only improves clinical outcomes but also reduces long-term healthcare expenditures. In essence, AI is pushing diabetes management upstream-toward earlier identification, predictive action, and ultimately, disease prevention.

What Is Driving the Rapid Global Adoption of AI in Diabetes Management?

The growth in the artificial intelligence (AI) in diabetes management market is driven by several factors rooted in technology advancement, healthcare transformation, and evolving patient expectations. The increasing global prevalence of diabetes-estimated to affect over half a billion people-has created an urgent need for scalable, cost-effective solutions that go beyond traditional clinical models. AI’s ability to deliver real-time, data-driven decision support at scale makes it ideally suited to address this challenge. Technological advancements in sensors, wearables, and mobile platforms have created an interconnected ecosystem where data can be collected continuously and unobtrusively, providing the raw material for AI analysis. On the consumer side, there is rising demand for digital health tools that offer personalized insights, reduce the burden of self-care, and improve quality of life. From a provider standpoint, AI solutions help mitigate clinician burnout by automating routine tasks, generating actionable alerts, and enhancing diagnostic accuracy. The integration of AI into cloud platforms, electronic medical records, and telemedicine systems further supports interoperability and scalability. Regulatory agencies and payers are beginning to recognize the value of AI in chronic disease management, leading to increased reimbursement coverage and policy support. Additionally, strategic investments and partnerships among medtech companies, pharmaceutical firms, and AI startups are accelerating product development and market expansion. In emerging economies, mobile-first AI applications are helping extend care to remote populations, democratizing access to quality diabetes care. Together, these factors are creating a robust and rapidly growing global market where AI stands at the center of a new, intelligent paradigm for managing diabetes.

SCOPE OF STUDY:

The report analyzes the Artificial Intelligence (AI) in Diabetes Management market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Device (Diagnostic Devices, Glucose Monitoring Devices, Insulin Delivery Devices); Technique (Case-based Reasoning Technique, Intelligent Data Analysis Technique)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 47 Featured) -

  • Abbott Laboratories
  • Apple Inc.
  • Beta Bionics
  • Bigfoot Biomedical, Inc.
  • Dexcom, Inc.
  • Diabeloop SA
  • DreaMed Diabetes Ltd.
  • Eyenuk, Inc.
  • Glooko Inc.
  • Google Inc.
  • IBM Corporation
  • Insulet Corporation
  • Medtronic PLC
  • Nemaura Medical Inc.
  • Novo Nordisk A/S
  • Roche Holding AG
  • Sanofi SA
  • Tandem Diabetes Care, Inc.
  • Virta Health Corp.
  • Wellthy Therapeutics Pvt. Ltd.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Artificial Intelligence (AI) in Diabetes Management - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Global Diabetes Burden Throws the Spotlight on AI-Driven Disease Management Tools
    • Use of Predictive Analytics for Hypoglycemia and Hyperglycemia Risk Monitoring Enhances Patient Safety
    • AI Integration With CGM Devices Supports Real-Time Glucose Trend Interpretation
    • Development of Personalized Insulin Dosing Algorithms Improves Treatment Precision
    • Use in Mobile Apps and Digital Health Platforms Expands Access to Remote Diabetes Care
    • AI-Powered Virtual Coaching Enhances Patient Engagement and Lifestyle Management
    • Adoption in Automated Insulin Delivery Systems Supports Closed-Loop Therapies
    • Use of AI for Complication Risk Prediction Boosts Preventive Care Initiatives
    • Integration With EHRs Enables Holistic Diabetes Profile Analysis
    • AI Models Trained on Multimodal Patient Data Improve Diagnostic Accuracy
    • Growth in Telemedicine and Digital Clinics Supports Wider Adoption of AI-Enabled Tools
    • Use in Population Health Management Strengthens Public Health Surveillance
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Artificial Intelligence (AI) in Diabetes Management Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Diabetes Management by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Artificial Intelligence (AI) in Diabetes Management by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 4: World 16-Year Perspective for Artificial Intelligence (AI) in Diabetes Management by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Diagnostic Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Diagnostic Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 7: World 16-Year Perspective for Diagnostic Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Glucose Monitoring Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Glucose Monitoring Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 10: World 16-Year Perspective for Glucose Monitoring Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Insulin Delivery Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Insulin Delivery Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 13: World 16-Year Perspective for Insulin Delivery Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Case-based Reasoning Technique by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Case-based Reasoning Technique by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 16: World 16-Year Perspective for Case-based Reasoning Technique by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Intelligent Data Analysis Technique by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Intelligent Data Analysis Technique by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 19: World 16-Year Perspective for Intelligent Data Analysis Technique by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Artificial Intelligence (AI) in Diabetes Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 20: USA Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Diabetes Management by Device - Diagnostic Devices, Glucose Monitoring Devices and Insulin Delivery Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 21: USA Historic Review for Artificial Intelligence (AI) in Diabetes Management by Device - Diagnostic Devices, Glucose Monitoring Devices and Insulin Delivery Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 22: USA 16-Year Perspective for Artificial Intelligence (AI) in Diabetes Management by Device - Percentage Breakdown of Value Sales for Diagnostic Devices, Glucose Monitoring Devices and Insulin Delivery Devices for the Years 2014, 2025 & 2030
    • TABLE 23: USA Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Diabetes Management by Technique - Case-based Reasoning Technique and Intelligent Data Analysis Technique - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Artificial Intelligence (AI) in Diabetes Management by Technique - Case-based Reasoning Technique and Intelligent Data Analysis Technique Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 25: USA 16-Year Perspective for Artificial Intelligence (AI) in Diabetes Management by Technique - Percentage Breakdown of Value Sales for Case-based Reasoning Technique and Intelligent Data Analysis Technique for the Years 2014, 2025 & 2030
  • CANADA
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Diabetes Management by Device - Diagnostic Devices, Glucose Monitoring Devices and Insulin Delivery Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 27: Canada Historic Review for Artificial Intelligence (AI) in Diabetes Management by Device - Diagnostic Devices, Glucose Monitoring Devices and Insulin Delivery Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 28: Canada 16-Year Perspective for Artificial Intelligence (AI) in Diabetes Management by Device - Percentage Breakdown of Value Sales for Diagnostic Devices, Glucose Monitoring Devices and Insulin Delivery Devices for the Years 2014, 2025 & 2030
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Diabetes Management by Technique - Case-based Reasoning Technique and Intelligent Data Analysis Technique - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Artificial Intelligence (AI) in Diabetes Management by Technique - Case-based Reasoning Technique and Intelligent Data Analysis Technique Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 31: Canada 16-Year Perspective for Artificial Intelligence (AI) in Diabetes Management by Technique - Percentage Breakdown of Value Sales for Case-based Reasoning Technique and Intelligent Data Analysis Technique for the Years 2014, 2025 & 2030
  • JAPAN
    • Artificial Intelligence (AI) in Diabetes Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Diabetes Management by Device - Diagnostic Devices, Glucose Monitoring Devices and Insulin Delivery Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Japan Historic Review for Artificial Intelligence (AI) in Diabetes Management by Device - Diagnostic Devices, Glucose Monitoring Devices and Insulin Delivery Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 34: Japan 16-Year Perspective for Artificial Intelligence (AI) in Diabetes Management by Device - Percentage Breakdown of Value Sales for Diagnostic Devices, Glucose Monitoring Devices and Insulin Delivery Devices for the Years 2014, 2025 & 2030
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Diabetes Management by Technique - Case-based Reasoning Technique and Intelligent Data Analysis Technique - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Artificial Intelligence (AI) in Diabetes Management by Technique - Case-based Reasoning Technique and Intelligent Data Analysis Technique Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 37: Japan 16-Year Perspective for Artificial Intelligence (AI) in Diabetes Management by Technique - Percentage Breakdown of Value Sales for Case-based Reasoning Technique and Intelligent Data Analysis Technique for the Years 2014, 2025 & 2030
  • CHINA
    • Artificial Intelligence (AI) in Diabetes Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 38: China Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Diabetes Management by Device - Diagnostic Devices, Glucose Monitoring Devices and Insulin Delivery Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: China Historic Review for Artificial Intelligence (AI) in Diabetes Management by Device - Diagnostic Devices, Glucose Monitoring Devices and Insulin Delivery Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 40: China 16-Year Perspective for Artificial Intelligence (AI) in Diabetes Management by Device - Percentage Breakdown of Value Sales for Diagnostic Devices, Glucose Monitoring Devices and Insulin Delivery Devices for the Years 2014, 2025 & 2030
    • TABLE 41: China Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Diabetes Management by Technique - Case-based Reasoning Technique and Intelligent Data Analysis Technique - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Artificial Intelligence (AI) in Diabetes Management by Technique - Case-based Reasoning Technique and Intelligent Data Analysis Technique Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 43: China 16-Year Perspective for Artificial Intelligence (AI) in Diabetes Management by Technique - Percentage Breakdown of Value Sales for Case-based Reasoning Technique and Intelligent Data Analysis Technique for the Years 2014, 2025 & 2030
  • EUROPE
    • Artificial Intelligence (AI) in Diabetes Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Diabetes Management by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 45: Europe Historic Review for Artificial Intelligence (AI) in Diabetes Management by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 46: Europe 16-Year Perspective for Artificial Intelligence (AI) in Diabetes Management by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Diabetes Management by Device - Diagnostic Devices, Glucose Monitoring Devices and Insulin Delivery Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Artificial Intelligence (AI) in Diabetes Management by Device - Diagnostic Devices, Glucose Monitoring Devices and Insulin Delivery Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 49: Europe 16-Year Perspective for Artificial Intelligence (AI) in Diabetes Management by Device - Percentage Breakdown of Value Sales for Diagnostic Devices, Glucose Monitoring Devices and Insulin Delivery Devices for the Years 2014, 2025 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Diabetes Management by Technique - Case-based Reasoning Technique and Intelligent Data Analysis Technique - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Artificial Intelligence (AI) in Diabetes Management by Technique - Case-based Reasoning Technique and Intelligent Data Analysis Technique Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Artificial Intelligence (AI) in Diabetes Management by Technique - Percentage Breakdown of Value Sales for Case-based Reasoning Technique and Intelligent Data Analysis Technique for the Years 2014, 2025 & 2030
  • FRANCE
    • Artificial Intelligence (AI) in Diabetes Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 53: France Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Diabetes Management by Device - Diagnostic Devices, Glucose Monitoring Devices and Insulin Delivery Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: France Historic Review for Artificial Intelligence (AI) in Diabetes Management by Device - Diagnostic Devices, Glucose Monitoring Devices and Insulin Delivery Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 55: France 16-Year Perspective for Artificial Intelligence (AI) in Diabetes Management by Device - Percentage Breakdown of Value Sales for Diagnostic Devices, Glucose Monitoring Devices and Insulin Delivery Devices for the Years 2014, 2025 & 2030
    • TABLE 56: France Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Diabetes Management by Technique - Case-based Reasoning Technique and Intelligent Data Analysis Technique - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Artificial Intelligence (AI) in Diabetes Management by Technique - Case-based Reasoning Technique and Intelligent Data Analysis Technique Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 58: France 16-Year Perspective for Artificial Intelligence (AI) in Diabetes Management by Technique - Percentage Breakdown of Value Sales for Case-based Reasoning Technique and Intelligent Data Analysis Technique for the Years 2014, 2025 & 2030
  • GERMANY
    • Artificial Intelligence (AI) in Diabetes Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 59: Germany Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Diabetes Management by Device - Diagnostic Devices, Glucose Monitoring Devices and Insulin Delivery Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Germany Historic Review for Artificial Intelligence (AI) in Diabetes Management by Device - Diagnostic Devices, Glucose Monitoring Devices and Insulin Delivery Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 61: Germany 16-Year Perspective for Artificial Intelligence (AI) in Diabetes Management by Device - Percentage Breakdown of Value Sales for Diagnostic Devices, Glucose Monitoring Devices and Insulin Delivery Devices for the Years 2014, 2025 & 2030
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Diabetes Management by Technique - Case-based Reasoning Technique and Intelligent Data Analysis Technique - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Artificial Intelligence (AI) in Diabetes Management by Technique - Case-based Reasoning Technique and Intelligent Data Analysis Technique Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 64: Germany 16-Year Perspective for Artificial Intelligence (AI) in Diabetes Management by Technique - Percentage Breakdown of Value Sales for Case-based Reasoning Technique and Intelligent Data Analysis Technique for the Years 2014, 2025 & 2030
  • ITALY
    • TABLE 65: Italy Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Diabetes Management by Device - Diagnostic Devices, Glucose Monitoring Devices and Insulin Delivery Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Italy Historic Review for Artificial Intelligence (AI) in Diabetes Management by Device - Diagnostic Devices, Glucose Monitoring Devices and Insulin Delivery Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 67: Italy 16-Year Perspective for Artificial Intelligence (AI) in Diabetes Management by Device - Percentage Breakdown of Value Sales for Diagnostic Devices, Glucose Monitoring Devices and Insulin Delivery Devices for the Years 2014, 2025 & 2030
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Diabetes Management by Technique - Case-based Reasoning Technique and Intelligent Data Analysis Technique - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Artificial Intelligence (AI) in Diabetes Management by Technique - Case-based Reasoning Technique and Intelligent Data Analysis Technique Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 70: Italy 16-Year Perspective for Artificial Intelligence (AI) in Diabetes Management by Technique - Percentage Breakdown of Value Sales for Case-based Reasoning Technique and Intelligent Data Analysis Technique for the Years 2014, 2025 & 2030
  • UNITED KINGDOM
    • Artificial Intelligence (AI) in Diabetes Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 71: UK Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Diabetes Management by Device - Diagnostic Devices, Glucose Monitoring Devices and Insulin Delivery Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: UK Historic Review for Artificial Intelligence (AI) in Diabetes Management by Device - Diagnostic Devices, Glucose Monitoring Devices and Insulin Delivery Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 73: UK 16-Year Perspective for Artificial Intelligence (AI) in Diabetes Management by Device - Percentage Breakdown of Value Sales for Diagnostic Devices, Glucose Monitoring Devices and Insulin Delivery Devices for the Years 2014, 2025 & 2030
    • TABLE 74: UK Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Diabetes Management by Technique - Case-based Reasoning Technique and Intelligent Data Analysis Technique - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Artificial Intelligence (AI) in Diabetes Management by Technique - Case-based Reasoning Technique and Intelligent Data Analysis Technique Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 76: UK 16-Year Perspective for Artificial Intelligence (AI) in Diabetes Management by Technique - Percentage Breakdown of Value Sales for Case-based Reasoning Technique and Intelligent Data Analysis Technique for the Years 2014, 2025 & 2030
  • SPAIN
    • TABLE 77: Spain Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Diabetes Management by Device - Diagnostic Devices, Glucose Monitoring Devices and Insulin Delivery Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Spain Historic Review for Artificial Intelligence (AI) in Diabetes Management by Device - Diagnostic Devices, Glucose Monitoring Devices and Insulin Delivery Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 79: Spain 16-Year Perspective for Artificial Intelligence (AI) in Diabetes Management by Device - Percentage Breakdown of Value Sales for Diagnostic Devices, Glucose Monitoring Devices and Insulin Delivery Devices for the Years 2014, 2025 & 2030
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Diabetes Management by Technique - Case-based Reasoning Technique and Intelligent Data Analysis Technique - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Artificial Intelligence (AI) in Diabetes Management by Technique - Case-based Reasoning Technique and Intelligent Data Analysis Technique Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 82: Spain 16-Year Perspective for Artificial Intelligence (AI) in Diabetes Management by Technique - Percentage Breakdown of Value Sales for Case-based Reasoning Technique and Intelligent Data Analysis Technique for the Years 2014, 2025 & 2030
  • RUSSIA
    • TABLE 83: Russia Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Diabetes Management by Device - Diagnostic Devices, Glucose Monitoring Devices and Insulin Delivery Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Russia Historic Review for Artificial Intelligence (AI) in Diabetes Management by Device - Diagnostic Devices, Glucose Monitoring Devices and Insulin Delivery Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 85: Russia 16-Year Perspective for Artificial Intelligence (AI) in Diabetes Management by Device - Percentage Breakdown of Value Sales for Diagnostic Devices, Glucose Monitoring Devices and Insulin Delivery Devices for the Years 2014, 2025 & 2030
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Diabetes Management by Technique - Case-based Reasoning Technique and Intelligent Data Analysis Technique - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Artificial Intelligence (AI) in Diabetes Management by Technique - Case-based Reasoning Technique and Intelligent Data Analysis Technique Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 88: Russia 16-Year Perspective for Artificial Intelligence (AI) in Diabetes Management by Technique - Percentage Breakdown of Value Sales for Case-based Reasoning Technique and Intelligent Data Analysis Technique for the Years 2014, 2025 & 2030
  • REST OF EUROPE
    • TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Diabetes Management by Device - Diagnostic Devices, Glucose Monitoring Devices and Insulin Delivery Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Rest of Europe Historic Review for Artificial Intelligence (AI) in Diabetes Management by Device - Diagnostic Devices, Glucose Monitoring Devices and Insulin Delivery Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 91: Rest of Europe 16-Year Perspective for Artificial Intelligence (AI) in Diabetes Management by Device - Percentage Breakdown of Value Sales for Diagnostic Devices, Glucose Monitoring Devices and Insulin Delivery Devices for the Years 2014, 2025 & 2030
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Diabetes Management by Technique - Case-based Reasoning Technique and Intelligent Data Analysis Technique - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Artificial Intelligence (AI) in Diabetes Management by Technique - Case-based Reasoning Technique and Intelligent Data Analysis Technique Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 94: Rest of Europe 16-Year Perspective for Artificial Intelligence (AI) in Diabetes Management by Technique - Percentage Breakdown of Value Sales for Case-based Reasoning Technique and Intelligent Data Analysis Technique for the Years 2014, 2025 & 2030
  • ASIA-PACIFIC
    • Artificial Intelligence (AI) in Diabetes Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Diabetes Management by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 96: Asia-Pacific Historic Review for Artificial Intelligence (AI) in Diabetes Management by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 97: Asia-Pacific 16-Year Perspective for Artificial Intelligence (AI) in Diabetes Management by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Diabetes Management by Device - Diagnostic Devices, Glucose Monitoring Devices and Insulin Delivery Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Artificial Intelligence (AI) in Diabetes Management by Device - Diagnostic Devices, Glucose Monitoring Devices and Insulin Delivery Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 100: Asia-Pacific 16-Year Perspective for Artificial Intelligence (AI) in Diabetes Management by Device - Percentage Breakdown of Value Sales for Diagnostic Devices, Glucose Monitoring Devices and Insulin Delivery Devices for the Years 2014, 2025 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Diabetes Management by Technique - Case-based Reasoning Technique and Intelligent Data Analysis Technique - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Artificial Intelligence (AI) in Diabetes Management by Technique - Case-based Reasoning Technique and Intelligent Data Analysis Technique Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 16-Year Perspective for Artificial Intelligence (AI) in Diabetes Management by Technique - Percentage Breakdown of Value Sales for Case-based Reasoning Technique and Intelligent Data Analysis Technique for the Years 2014, 2025 & 2030
  • AUSTRALIA
    • Artificial Intelligence (AI) in Diabetes Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 104: Australia Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Diabetes Management by Device - Diagnostic Devices, Glucose Monitoring Devices and Insulin Delivery Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Australia Historic Review for Artificial Intelligence (AI) in Diabetes Management by Device - Diagnostic Devices, Glucose Monitoring Devices and Insulin Delivery Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 106: Australia 16-Year Perspective for Artificial Intelligence (AI) in Diabetes Management by Device - Percentage Breakdown of Value Sales for Diagnostic Devices, Glucose Monitoring Devices and Insulin Delivery Devices for the Years 2014, 2025 & 2030
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Diabetes Management by Technique - Case-based Reasoning Technique and Intelligent Data Analysis Technique - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Artificial Intelligence (AI) in Diabetes Management by Technique - Case-based Reasoning Technique and Intelligent Data Analysis Technique Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 109: Australia 16-Year Perspective for Artificial Intelligence (AI) in Diabetes Management by Technique - Percentage Breakdown of Value Sales for Case-based Reasoning Technique and Intelligent Data Analysis Technique for the Years 2014, 2025 & 2030
  • INDIA
    • Artificial Intelligence (AI) in Diabetes Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 110: India Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Diabetes Management by Device - Diagnostic Devices, Glucose Monitoring Devices and Insulin Delivery Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: India Historic Review for Artificial Intelligence (AI) in Diabetes Management by Device - Diagnostic Devices, Glucose Monitoring Devices and Insulin Delivery Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 112: India 16-Year Perspective for Artificial Intelligence (AI) in Diabetes Management by Device - Percentage Breakdown of Value Sales for Diagnostic Devices, Glucose Monitoring Devices and Insulin Delivery Devices for the Years 2014, 2025 & 2030
    • TABLE 113: India Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Diabetes Management by Technique - Case-based Reasoning Technique and Intelligent Data Analysis Technique - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Artificial Intelligence (AI) in Diabetes Management by Technique - Case-based Reasoning Technique and Intelligent Data Analysis Technique Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 115: India 16-Year Perspective for Artificial Intelligence (AI) in Diabetes Management by Technique - Percentage Breakdown of Value Sales for Case-based Reasoning Technique and Intelligent Data Analysis Technique for the Years 2014, 2025 & 2030
  • SOUTH KOREA
    • TABLE 116: South Korea Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Diabetes Management by Device - Diagnostic Devices, Glucose Monitoring Devices and Insulin Delivery Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: South Korea Historic Review for Artificial Intelligence (AI) in Diabetes Management by Device - Diagnostic Devices, Glucose Monitoring Devices and Insulin Delivery Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 118: South Korea 16-Year Perspective for Artificial Intelligence (AI) in Diabetes Management by Device - Percentage Breakdown of Value Sales for Diagnostic Devices, Glucose Monitoring Devices and Insulin Delivery Devices for the Years 2014, 2025 & 2030
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Diabetes Management by Technique - Case-based Reasoning Technique and Intelligent Data Analysis Technique - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Artificial Intelligence (AI) in Diabetes Management by Technique - Case-based Reasoning Technique and Intelligent Data Analysis Technique Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 121: South Korea 16-Year Perspective for Artificial Intelligence (AI) in Diabetes Management by Technique - Percentage Breakdown of Value Sales for Case-based Reasoning Technique and Intelligent Data Analysis Technique for the Years 2014, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 122: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Diabetes Management by Device - Diagnostic Devices, Glucose Monitoring Devices and Insulin Delivery Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Rest of Asia-Pacific Historic Review for Artificial Intelligence (AI) in Diabetes Management by Device - Diagnostic Devices, Glucose Monitoring Devices and Insulin Delivery Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 124: Rest of Asia-Pacific 16-Year Perspective for Artificial Intelligence (AI) in Diabetes Management by Device - Percentage Breakdown of Value Sales for Diagnostic Devices, Glucose Monitoring Devices and Insulin Delivery Devices for the Years 2014, 2025 & 2030
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Diabetes Management by Technique - Case-based Reasoning Technique and Intelligent Data Analysis Technique - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Artificial Intelligence (AI) in Diabetes Management by Technique - Case-based Reasoning Technique and Intelligent Data Analysis Technique Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 16-Year Perspective for Artificial Intelligence (AI) in Diabetes Management by Technique - Percentage Breakdown of Value Sales for Case-based Reasoning Technique and Intelligent Data Analysis Technique for the Years 2014, 2025 & 2030
  • LATIN AMERICA
    • Artificial Intelligence (AI) in Diabetes Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 128: Latin America Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Diabetes Management by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 129: Latin America Historic Review for Artificial Intelligence (AI) in Diabetes Management by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 130: Latin America 16-Year Perspective for Artificial Intelligence (AI) in Diabetes Management by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Diabetes Management by Device - Diagnostic Devices, Glucose Monitoring Devices and Insulin Delivery Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Artificial Intelligence (AI) in Diabetes Management by Device - Diagnostic Devices, Glucose Monitoring Devices and Insulin Delivery Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 133: Latin America 16-Year Perspective for Artificial Intelligence (AI) in Diabetes Management by Device - Percentage Breakdown of Value Sales for Diagnostic Devices, Glucose Monitoring Devices and Insulin Delivery Devices for the Years 2014, 2025 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Diabetes Management by Technique - Case-based Reasoning Technique and Intelligent Data Analysis Technique - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Artificial Intelligence (AI) in Diabetes Management by Technique - Case-based Reasoning Technique and Intelligent Data Analysis Technique Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 136: Latin America 16-Year Perspective for Artificial Intelligence (AI) in Diabetes Management by Technique - Percentage Breakdown of Value Sales for Case-based Reasoning Technique and Intelligent Data Analysis Technique for the Years 2014, 2025 & 2030
  • ARGENTINA
    • TABLE 137: Argentina Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Diabetes Management by Device - Diagnostic Devices, Glucose Monitoring Devices and Insulin Delivery Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Argentina Historic Review for Artificial Intelligence (AI) in Diabetes Management by Device - Diagnostic Devices, Glucose Monitoring Devices and Insulin Delivery Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 139: Argentina 16-Year Perspective for Artificial Intelligence (AI) in Diabetes Management by Device - Percentage Breakdown of Value Sales for Diagnostic Devices, Glucose Monitoring Devices and Insulin Delivery Devices for the Years 2014, 2025 & 2030
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Diabetes Management by Technique - Case-based Reasoning Technique and Intelligent Data Analysis Technique - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for Artificial Intelligence (AI) in Diabetes Management by Technique - Case-based Reasoning Technique and Intelligent Data Analysis Technique Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 142: Argentina 16-Year Perspective for Artificial Intelligence (AI) in Diabetes Management by Technique - Percentage Breakdown of Value Sales for Case-based Reasoning Technique and Intelligent Data Analysis Technique for the Years 2014, 2025 & 2030
  • BRAZIL
    • TABLE 143: Brazil Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Diabetes Management by Device - Diagnostic Devices, Glucose Monitoring Devices and Insulin Delivery Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Brazil Historic Review for Artificial Intelligence (AI) in Diabetes Management by Device - Diagnostic Devices, Glucose Monitoring Devices and Insulin Delivery Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 145: Brazil 16-Year Perspective for Artificial Intelligence (AI) in Diabetes Management by Device - Percentage Breakdown of Value Sales for Diagnostic Devices, Glucose Monitoring Devices and Insulin Delivery Devices for the Years 2014, 2025 & 2030
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Diabetes Management by Technique - Case-based Reasoning Technique and Intelligent Data Analysis Technique - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for Artificial Intelligence (AI) in Diabetes Management by Technique - Case-based Reasoning Technique and Intelligent Data Analysis Technique Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 148: Brazil 16-Year Perspective for Artificial Intelligence (AI) in Diabetes Management by Technique - Percentage Breakdown of Value Sales for Case-based Reasoning Technique and Intelligent Data Analysis Technique for the Years 2014, 2025 & 2030
  • MEXICO
    • TABLE 149: Mexico Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Diabetes Management by Device - Diagnostic Devices, Glucose Monitoring Devices and Insulin Delivery Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Mexico Historic Review for Artificial Intelligence (AI) in Diabetes Management by Device - Diagnostic Devices, Glucose Monitoring Devices and Insulin Delivery Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 151: Mexico 16-Year Perspective for Artificial Intelligence (AI) in Diabetes Management by Device - Percentage Breakdown of Value Sales for Diagnostic Devices, Glucose Monitoring Devices and Insulin Delivery Devices for the Years 2014, 2025 & 2030
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Diabetes Management by Technique - Case-based Reasoning Technique and Intelligent Data Analysis Technique - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for Artificial Intelligence (AI) in Diabetes Management by Technique - Case-based Reasoning Technique and Intelligent Data Analysis Technique Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 154: Mexico 16-Year Perspective for Artificial Intelligence (AI) in Diabetes Management by Technique - Percentage Breakdown of Value Sales for Case-based Reasoning Technique and Intelligent Data Analysis Technique for the Years 2014, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 155: Rest of Latin America Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Diabetes Management by Device - Diagnostic Devices, Glucose Monitoring Devices and Insulin Delivery Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Rest of Latin America Historic Review for Artificial Intelligence (AI) in Diabetes Management by Device - Diagnostic Devices, Glucose Monitoring Devices and Insulin Delivery Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 157: Rest of Latin America 16-Year Perspective for Artificial Intelligence (AI) in Diabetes Management by Device - Percentage Breakdown of Value Sales for Diagnostic Devices, Glucose Monitoring Devices and Insulin Delivery Devices for the Years 2014, 2025 & 2030
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Diabetes Management by Technique - Case-based Reasoning Technique and Intelligent Data Analysis Technique - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for Artificial Intelligence (AI) in Diabetes Management by Technique - Case-based Reasoning Technique and Intelligent Data Analysis Technique Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 160: Rest of Latin America 16-Year Perspective for Artificial Intelligence (AI) in Diabetes Management by Technique - Percentage Breakdown of Value Sales for Case-based Reasoning Technique and Intelligent Data Analysis Technique for the Years 2014, 2025 & 2030
  • MIDDLE EAST
    • Artificial Intelligence (AI) in Diabetes Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 161: Middle East Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Diabetes Management by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 162: Middle East Historic Review for Artificial Intelligence (AI) in Diabetes Management by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 163: Middle East 16-Year Perspective for Artificial Intelligence (AI) in Diabetes Management by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Diabetes Management by Device - Diagnostic Devices, Glucose Monitoring Devices and Insulin Delivery Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Artificial Intelligence (AI) in Diabetes Management by Device - Diagnostic Devices, Glucose Monitoring Devices and Insulin Delivery Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 166: Middle East 16-Year Perspective for Artificial Intelligence (AI) in Diabetes Management by Device - Percentage Breakdown of Value Sales for Diagnostic Devices, Glucose Monitoring Devices and Insulin Delivery Devices for the Years 2014, 2025 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Diabetes Management by Technique - Case-based Reasoning Technique and Intelligent Data Analysis Technique - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Artificial Intelligence (AI) in Diabetes Management by Technique - Case-based Reasoning Technique and Intelligent Data Analysis Technique Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 169: Middle East 16-Year Perspective for Artificial Intelligence (AI) in Diabetes Management by Technique - Percentage Breakdown of Value Sales for Case-based Reasoning Technique and Intelligent Data Analysis Technique for the Years 2014, 2025 & 2030
  • IRAN
    • TABLE 170: Iran Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Diabetes Management by Device - Diagnostic Devices, Glucose Monitoring Devices and Insulin Delivery Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Iran Historic Review for Artificial Intelligence (AI) in Diabetes Management by Device - Diagnostic Devices, Glucose Monitoring Devices and Insulin Delivery Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 172: Iran 16-Year Perspective for Artificial Intelligence (AI) in Diabetes Management by Device - Percentage Breakdown of Value Sales for Diagnostic Devices, Glucose Monitoring Devices and Insulin Delivery Devices for the Years 2014, 2025 & 2030
    • TABLE 173: Iran Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Diabetes Management by Technique - Case-based Reasoning Technique and Intelligent Data Analysis Technique - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for Artificial Intelligence (AI) in Diabetes Management by Technique - Case-based Reasoning Technique and Intelligent Data Analysis Technique Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 175: Iran 16-Year Perspective for Artificial Intelligence (AI) in Diabetes Management by Technique - Percentage Breakdown of Value Sales for Case-based Reasoning Technique and Intelligent Data Analysis Technique for the Years 2014, 2025 & 2030
  • ISRAEL
    • TABLE 176: Israel Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Diabetes Management by Device - Diagnostic Devices, Glucose Monitoring Devices and Insulin Delivery Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Israel Historic Review for Artificial Intelligence (AI) in Diabetes Management by Device - Diagnostic Devices, Glucose Monitoring Devices and Insulin Delivery Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 178: Israel 16-Year Perspective for Artificial Intelligence (AI) in Diabetes Management by Device - Percentage Breakdown of Value Sales for Diagnostic Devices, Glucose Monitoring Devices and Insulin Delivery Devices for the Years 2014, 2025 & 2030
    • TABLE 179: Israel Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Diabetes Management by Technique - Case-based Reasoning Technique and Intelligent Data Analysis Technique - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for Artificial Intelligence (AI) in Diabetes Management by Technique - Case-based Reasoning Technique and Intelligent Data Analysis Technique Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 181: Israel 16-Year Perspective for Artificial Intelligence (AI) in Diabetes Management by Technique - Percentage Breakdown of Value Sales for Case-based Reasoning Technique and Intelligent Data Analysis Technique for the Years 2014, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 182: Saudi Arabia Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Diabetes Management by Device - Diagnostic Devices, Glucose Monitoring Devices and Insulin Delivery Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Saudi Arabia Historic Review for Artificial Intelligence (AI) in Diabetes Management by Device - Diagnostic Devices, Glucose Monitoring Devices and Insulin Delivery Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 184: Saudi Arabia 16-Year Perspective for Artificial Intelligence (AI) in Diabetes Management by Device - Percentage Breakdown of Value Sales for Diagnostic Devices, Glucose Monitoring Devices and Insulin Delivery Devices for the Years 2014, 2025 & 2030
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Diabetes Management by Technique - Case-based Reasoning Technique and Intelligent Data Analysis Technique - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for Artificial Intelligence (AI) in Diabetes Management by Technique - Case-based Reasoning Technique and Intelligent Data Analysis Technique Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 187: Saudi Arabia 16-Year Perspective for Artificial Intelligence (AI) in Diabetes Management by Technique - Percentage Breakdown of Value Sales for Case-based Reasoning Technique and Intelligent Data Analysis Technique for the Years 2014, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 188: UAE Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Diabetes Management by Device - Diagnostic Devices, Glucose Monitoring Devices and Insulin Delivery Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: UAE Historic Review for Artificial Intelligence (AI) in Diabetes Management by Device - Diagnostic Devices, Glucose Monitoring Devices and Insulin Delivery Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 190: UAE 16-Year Perspective for Artificial Intelligence (AI) in Diabetes Management by Device - Percentage Breakdown of Value Sales for Diagnostic Devices, Glucose Monitoring Devices and Insulin Delivery Devices for the Years 2014, 2025 & 2030
    • TABLE 191: UAE Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Diabetes Management by Technique - Case-based Reasoning Technique and Intelligent Data Analysis Technique - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for Artificial Intelligence (AI) in Diabetes Management by Technique - Case-based Reasoning Technique and Intelligent Data Analysis Technique Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 193: UAE 16-Year Perspective for Artificial Intelligence (AI) in Diabetes Management by Technique - Percentage Breakdown of Value Sales for Case-based Reasoning Technique and Intelligent Data Analysis Technique for the Years 2014, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 194: Rest of Middle East Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Diabetes Management by Device - Diagnostic Devices, Glucose Monitoring Devices and Insulin Delivery Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Rest of Middle East Historic Review for Artificial Intelligence (AI) in Diabetes Management by Device - Diagnostic Devices, Glucose Monitoring Devices and Insulin Delivery Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 196: Rest of Middle East 16-Year Perspective for Artificial Intelligence (AI) in Diabetes Management by Device - Percentage Breakdown of Value Sales for Diagnostic Devices, Glucose Monitoring Devices and Insulin Delivery Devices for the Years 2014, 2025 & 2030
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Diabetes Management by Technique - Case-based Reasoning Technique and Intelligent Data Analysis Technique - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for Artificial Intelligence (AI) in Diabetes Management by Technique - Case-based Reasoning Technique and Intelligent Data Analysis Technique Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 199: Rest of Middle East 16-Year Perspective for Artificial Intelligence (AI) in Diabetes Management by Technique - Percentage Breakdown of Value Sales for Case-based Reasoning Technique and Intelligent Data Analysis Technique for the Years 2014, 2025 & 2030
  • AFRICA
    • Artificial Intelligence (AI) in Diabetes Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 200: Africa Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Diabetes Management by Device - Diagnostic Devices, Glucose Monitoring Devices and Insulin Delivery Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Africa Historic Review for Artificial Intelligence (AI) in Diabetes Management by Device - Diagnostic Devices, Glucose Monitoring Devices and Insulin Delivery Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 202: Africa 16-Year Perspective for Artificial Intelligence (AI) in Diabetes Management by Device - Percentage Breakdown of Value Sales for Diagnostic Devices, Glucose Monitoring Devices and Insulin Delivery Devices for the Years 2014, 2025 & 2030
    • TABLE 203: Africa Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Diabetes Management by Technique - Case-based Reasoning Technique and Intelligent Data Analysis Technique - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for Artificial Intelligence (AI) in Diabetes Management by Technique - Case-based Reasoning Technique and Intelligent Data Analysis Technique Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 205: Africa 16-Year Perspective for Artificial Intelligence (AI) in Diabetes Management by Technique - Percentage Breakdown of Value Sales for Case-based Reasoning Technique and Intelligent Data Analysis Technique for the Years 2014, 2025 & 2030

IV. COMPETITION